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Abstract
The luciferase protein fragment complementation assay is a powerful tool for studying protein-protein interactions. Two
inactive fragments of luciferase are genetically fused to interacting proteins, and when these two proteins interact, the
luciferase fragments can reversibly associate and reconstitute enzyme activity. Though this technology has been used
extensively in live eukaryotic cells, split luciferase complementation has not yet been applied to studies of dynamic protein-
protein interactions in live bacteria. As proof of concept and to develop a new tool for studies of bacterial chemotaxis,
fragments of Renilla luciferase (Rluc) were fused to the chemotaxis-associated response regulator CheY3 and its
phosphatase CheZ in the enteric pathogen Vibrio cholerae. Luciferase activity was dependent on the presence of both
CheY3 and CheZ fusion proteins, demonstrating the specificity of the assay. Furthermore, enzyme activity was markedly
reduced in V. cholerae chemotaxis mutants, suggesting that this approach can measure defects in chemotactic signaling.
However, attempts to measure changes in dynamic CheY3-CheZ interactions in response to various chemoeffectors were
undermined by nonspecific inhibition of the full-length luciferase. These observations reveal an unexpected limitation of
split Rluc complementation that may have implications for existing data and highlight the need for great caution when
evaluating small molecule effects on dynamic protein-protein interactions using the split luciferase technology.
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Introduction
Genetically encoded reporters have revolutionized the study of
bacterial protein-protein interactions. Two-hybrid systems, which
couple transcriptional activation of a reporter gene to protein
binding, have been widely used to characterize novel interaction
partners [1]. Protein fragment complementation assays (PCA), in
which two inactive fragments of a monomeric reporter, such as b-
galactosidase or green fluorescent protein, are fused to interacting
proteins, have also been used to measure binding interactions
[2,3]. However, both of these approaches typically suffer from
limitations (e.g., lag time of transcriptional activation or fluores-
cent protein maturation, irreversible signal amplification over
time) that preclude real-time analyses of dynamic interactions.
Fluorescence and bioluminescence resonance energy transfer
(FRET and BRET, respectively) assays can overcome these
limitations [4,5], but are more technically demanding. Thus, a
tractable assay that enables quantitative and sensitive measure-
ments of dynamic interactions in real-time would be a powerful
addition to the existing toolkit for studies of bacterial protein
interactions.
Luciferase protein fragment complementation (a.k.a. split
luciferase complementation) is a recently described PCA that has
been used to analyze dynamic protein-protein interactions in live
mammalian cells [6–10]. This assay relies on the division of a
bioluminescent luciferase enzyme into two inactive fragments that
are genetically fused to interacting proteins. When these two
proteins interact, the luciferase fragments can associate, thereby
reconstituting luciferase activity. Importantly, unlike fluorescent
protein complementation strategies, split luciferase complementa-
tion is reversible; it can be used to monitor protein-protein
interactions in real-time, unlike two-hybrid approaches and most
other protein fragment complementation assays; finally, unlike
FRET/BRET, it does not require monitoring of filtered light
emissions [3,10–12]. Notably, this technology was recently
adapted to monitor the assembly of a stable protein complex in
Salmonella [13].
We hypothesized that split luciferase complementation could
represent a versatile approach to studying dynamic protein-protein
interactions in bacteria. Though several luciferase enzymes have
been developed into split reporters, we chose to use recently
described fragments of Renilla reniformis luciferase (Rluc) [11] for
our assay because the light-emitting substrate of Rluc, coelenter-
azine (clz), can easily pass through the cell envelope of Gram-
negative bacteria [13,14], unlike the more common luciferase
substrate D-luciferin, which requires acidic pH for optimal
membrane permeability [15,16]. As a first application for proof
of concept, we fused these fragments to two chemotaxis proteins
PLOS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e43175from Vibrio cholerae, the curved Gram-negative bacterium that
causes human cholera.
Classically, bacterial chemotaxis reflects the sensing of external
stimuli by membrane-associated receptors that transmit a signal
through a cytoplasmic cascade that modulates flagellar rotation
[17]. Membrane-embedded methyl-accepting chemotaxis proteins
(MCPs) initiate chemotactic signaling upon detecting a change in
local chemical gradients. Binding of a chemorepellent (or a
decrease in chemoattractant binding) to its cognate MCP induces
a conformational change that leads to autophosphorylation of a
cytosolic kinase, CheA. CheA subsequently phosphorylates the
response regulator CheY, which diffuses across the cell and binds
the flagellar motor switch protein FliM. This binding switches the
direction of flagellar rotation, which induces random reorientation
of the cell. The lifetime of phosphorylated CheY is tightly
regulated by the phosphatase CheZ, which hydrolyzes CheY’s
phosphate group, thereby terminating the chemotactic signal.
Pathway activity is also regulated by methyltransferase and
methylesterase proteins (CheR and CheB, respectively), which
modulate pathway sensitivity. Collectively, these proteins allow
bacteria to maintain their direction (straight swimming) under
favorable conditions, and alter their direction (tumbling) under
adverse conditions.
V. cholerae encodes an unusually large number of putative MCPs,
as well as three potentially independent clusters of downstream
signaling proteins (chemotaxis clusters I, II, and III) [18,19].
Several cluster II genes, such as cheY3 and cheA2, are required for
chemotaxis in vitro [20]; however, genes from the other two
clusters remain largely uncharacterized, and ligands have not been
identified for any of the receptors.
Progress in studies of bacterial chemotaxis has been hindered by
a dependence on low-throughput and/or semi-quantitative
chemotaxis assays (i.e., capillary assays, soft-agar swarm plate
assays) [21,22]. An assay based on the split luciferase technology
could provide a sensitive, quantitative, and rapid microplate-based
approach to studying bacterial chemotaxis, with particular utility
for characterizing novel chemoeffectors. Importantly, elegant
BRET and FRET analyses of chemotaxis by Berg and colleagues
have demonstrated that the interaction of CheY and CheZ
proteins in E. coli is directly proportional to chemotaxis pathway
activity [14,23]. However, due to their relative technical
complexity, these assays are not widely used or easily adapted to
a high-throughput format. We hypothesized that fusion of Rluc
fragments to homologous proteins from V. cholerae would enable a
direct measure of chemotactic responses and provide a more
tractable platform for chemoeffector characterization (Figure 1).
Here, we demonstrate that an Rluc-based PCA can be used to
measure CheY3-CheZ interactions in V. cholerae and that this
approach can quantify differences in chemotactic signaling.
However, nonspecific inhibition of Rluc activity by small molecule
effectors compromises the utility of this technique in measuring
dynamic protein-protein interactions. These findings uncover a
critical limitation of split luciferase complementation that may
have broad implications for existing and future applications of this
technology.
Materials and Methods
Growth Conditions and Media
V. cholerae and E. coli were grown at 37uC in LB medium or on
LB agar plates supplemented as needed with the following
antibiotics: 5 mg/mL chloramphenicol and 200 mg/mL strepto-
mycin (V. cholerae); 20 mg/mL chloramphenicol (E. coli).
Strains and Plasmids
A complete list of the strains, plasmids, and primers used in this
study can be found in the Supplemental Information (Table S1, S2,
and S3). The V. cholerae El Tor clinical isolate C6706 was used to
generateallV.choleraemutantstrains.TheE.colistrainsDH5alpirand
SM10lpir were used for cloning and for conjugation, respectively,
and MG1655 wasused for bioluminescence assays.
Strain SR28 (Dche2, a deletion which encompasses the entire V.
cholerae chemotaxis cluster II) was generated using standard allele
exchange techniques as previously described [24]. Strains SR33
(Dche1che2che3) and DcheY3cheZ were similarly prepared using
derivatives of plasmid pCVD442 [25]. Strain SR33 was created by
consecutive deletions of chemotaxis clusters I, II, and III using
plasmids pSR1157, pSR1020, and pSR1158, respectively. Strain
DcheY3cheZ was created by simultaneously deleting the adjacent
cheY3 and cheZ genes of chemotaxis cluster II using plasmid
pCVD442-DcheY3cheZ. Plasmids pSR1157, pSR1020, pSR1158,
and pCVD442-DcheY3cheZ were conjugated into V. cholerae using
E. coli strain SM10lpir [26].
Plasmid pSR1157 was constructed by PCR amplification of the
up- and downstream regions flanking genes vc1394 and vc1406,
respectively, using primer pairs che1-cc/che1-dd and che1-aa/
che1-bb and V. cholerae C6706 genomic DNA as template. Equal
amounts of these PCR products were combined and used as
template in a third PCR reaction using primers che1-aa and che1-
dd. The resulting product was digested with XbaI and ligated into
similarlydigestedpCVD442plasmidtogeneratepSR1157.Plasmid
pSR1020 was constructed as previously described [24]. Plasmid
pSR1158 was constructed by PCR amplification of the up- and
downstream regions flanking genes vca1088 and vca1096, respec-
tively, using primer pairs che3-cc/che3-dd and che3-aa/che3-bb
and V. cholerae C6706 genomic DNA as template. Equal amounts of
these PCR products were combined and used as template in a third
PCR reaction using primers che3-aa and che3-dd. The resulting
product was digested with XbaI and ligated into similarly digested
pCVD442 plasmid to generate pSR1158.
Plasmid pCVD442-DcheY3cheZ was constructed by PCR ampli-
fication of the regions flanking the cheY3 (vc2065) and cheZ (vc2064)
genes of chemotaxis cluster II using V. cholerae C6706 genomic
DNA as template. Primers SKH-51 and SKH-52 were used to
amplify the region downstream of cheY3, and primers SKH-53 and
SKH-54 were used to amplify the region upstream of cheZ. Equal
amounts of these PCR products were then combined and used as
template in a final PCR reaction with primers SKH-51 and SKH-
54. The resulting product was digested with XbaI and ligated into
similarly digested pCVD442 plasmid to generate pCVD442-
DcheY3cheZ.
The rluc gene was cloned from the pRL-null vector (Promega).
The cheY3 and cheZ genes were cloned from V. cholerae C6706
genomic DNA. Split Rluc complementation fragments RlucN and
RlucC corresponded to amino acids 1–110 and 111–311,
respectively. A T2A mutation was introduced in RlucN to
preserve the amino acid sequence used in the original split Rluc
construct [11,27]. Fusions to CheY3 and CheZ were constructed
by PCR using primers with complementary overhangs. Following
initial amplification of each chemotaxis gene and Rluc fragment, a
second round of PCR was used to anneal cheY3 with rlucN and cheZ
with rlucC. A ribosome-binding site was introduced upstream of
cheZ (and the rlucC fragment of the control plasmid) to enable
tandem assembly of both Rluc fusions (and the Rluc fragments
alone) into a single expression vector. The cheY3-rlucN and cheZ-
rlucC inserts were sequentially introduced into pBAD33 (chloram-
phenicol resistant) under an arabinose-inducible promoter using
the KpnI/XbaI and XbaI/SphI restriction sites, respectively, to
Renilla Luciferase Inhibition
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pBAD33 using the same restriction sites to give plasmid pRlucN-
RlucC. Plasmid pRluc was constructed by PCR amplification of
the rluc gene using primers SKH-71 and SKH-76 followed by
digestion with KpnI/SphI and ligation into similarly digested
pBAD33. The final constructs were confirmed by DNA sequenc-
ing and transformed into V. cholerae and E. coli via electroporation.
Preparation of Cells for Bioluminescence Assays
An overnight culture of V. cholerae or E. coli was prepared in 2-
mL LB supplemented with chloramphenicol and inoculated with
cells from a frozen glycerol stock. The culture was incubated at
37uC with shaking at 250–275 rpm. The following day, the
overnight culture was diluted 1:100 in 5 mL fresh LB-chloram-
phenicol containing 0.2% (v/v) L-arabinose, which conferred
optimal restoration of swarming activity in DcheY3cheZ V. cholerae
cells, and grown for 3 h at 37uC on a rotary shaker to an
OD,1. The culture was washed twice with phosphate buffered
saline (PBS; pH 7), adjusted to an OD,0.4–0.5, and aliquoted
into a white 96-well plate in triplicate.
Bioluminescence Assays
Aliquots of native coelenterazine (clz) or benzyl-coelenterazine
(clz-h) (NanoLight) dissolved in ethanol were stored at 280uC.
Solutions (30 mM in distilled water) of D-glucose (American
Bioanalytical), L-serine, L-alanine, L-arginine, D-mannose, and
nickel chloride (Sigma) were prepared and used at a concentration
of 1 mM. Prior to each assay, a single aliquot of clz/clz-h was
thawed, diluted in PBS to a final concentration of 250 mM, and
incubated in the dark at room temperature for 1 h to stabilize the
clz/clz-h signal. To measure changes in split Rluc complementa-
tion resulting from small molecule-induced effects on CheY3-
CheZ binding, we established conditions that would provide a
stable split Rluc signal. Because the kinetics of Rluc luminescence
are characterized by a rapid drop in signal intensity over time [14],
obtaining a stable baseline is essential for comparing pre- and post-
stimulation values. We determined that incubating cells with clz
for 30 min at room temperature prior to initiating the biolumi-
nescence read produced a consistently stable split Rluc signal.
Thus, clz/clz-h was added to a final concentration of 7.5 mMt o
the PBS-washed cells, which were subsequently incubated in the
dark for 30 min at room temperature to allow the luciferase-
generated signal to stabilize. The total luminescence of each well
was then measured every minute for a total of 5 min with an
integration time of 1 sec using a SpectraMax L Luminescence
Microplate Reader (Molecular Devices). Immediately thereafter, a
single chemoeffector (or an equal volume of distilled water) was
manually injected into each well and a second luminescence read
was initiated as before. Data analysis was performed using
Microsoft Excel.
Western Blot Analysis
For analysis of CheY3-RlucN/CheZ-RlucC expression levels in
different genetic backgrounds, 1 mL of cells from cultures of equal
OD was centrifuged for 1 min at 15 krpm and frozen at 280uC.
The following day, cells were resuspended in 150 mL 50 mM Tris
buffer (pH 8) containing 1% (v/v) sodium dodecyl sulfate and
incubatedat95uCfor5 min.Cellswerelysedbysonication(101-sec
pulses at an output setting of 5; Fisher Scientific Model 60 Sonic
Dismembrator), treated with 4X NuPAGE LDS sample buffer (Life
Technologies) containing 4 mM dithiothreitol, and incubated at
65uC for 10 min prior to SDS-PAGE and immunoblotting with the
anti-Rluc antibody (1:100,000 dilution; mouse monoclonal, clone
5B11.2;Millipore).Proteinbandsweredetectedusingahorseradish
peroxidase-conjugated secondary antibody (1:2000 dilution; goat
anti-mouse IgG-HRP, sc-2005; Santa Cruz Biotechnology) and
chemiluminescent reagents (Pierce).
Results
Split Rluc Complementation Measures CheY3-CheZ
Interaction in Vibrio cholerae
To explore the utility of split Rluc complementation for probing
dynamic protein-protein interactions in V. cholerae, we applied the
technology toward the goal of developing a novel chemotaxis assay
that could in principle enable rapid, quantitative measurements of
chemotaxis in response to chemotactic stimuli. Since previous
BRET- and FRET-based analyses of chemotactic signaling in
E. coli [14,23] demonstrated that the interaction of the CheY and
CheZ proteins is directly proportional to chemotaxis pathway
Figure 1. Design of an Rluc-based PCA for studies of Vibrio cholerae chemotaxis. CheY3 and CheZ proteins fused to inactive Rluc N- and C-
terminal fragments, respectively, associate upon CheY3 phosphorylation, reconstituting full-length Rluc, which oxidizes the light-emitting substrate
coelenterazine (clz).
doi:10.1371/journal.pone.0043175.g001
Renilla Luciferase Inhibition
PLOS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e43175activity, we reasoned that fusion of Rluc fragments to homologous
proteins from V. cholerae (CheY3 and CheZ, respectively) would
enable a direct measure of chemotactic responses. Notably, unlike
existing chemotaxis assays, we envisioned that split Rluc comple-
mentation performed in a microplate-based format might also
provide a tractable platform for high-throughput studies of
V. cholerae chemotaxis.
For the design of our Rluc-based PCA, we used recently
described Rluc fragments that provided sensitive, quantitative
measurements of dynamic protein interactions with a high signal-
to-noise ratio in mammalian cells [11]. Plasmids were constructed
encoding the V. cholerae chemotaxis cluster II genes cheY3 and cheZ
fused to the N- and C-terminal fragments of Rluc (rlucN and rlucC),
respectively, by a 14-amino acid flexible linker. RlucN was fused to
either the N- or C-terminus of CheY3, while RlucC was fused to
the C-terminus of CheZ; structural comparisons to homologous
proteins from E. coli suggested this fusion strategy would yield the
best split Rluc complementation upon binding of CheY3 to CheZ.
These constructs, as well as various control constructs, were
introduced into wild-type and DcheY3cheZ V. cholerae and evaluated
for their ability to reconstitute luciferase activity.
The luciferase activity of cells co-expressing CheY3-RlucN and
CheZ-RlucC far exceeded that generated by cells co-expressing
unfused RlucN and RlucC (,20-fold difference in luminescence
intensity; Figure 2), suggesting that split Rluc complementation is
dependent on CheY3-CheZ interaction. Expression of individual
CheY3-RlucN or CheZ-RlucC fusion proteins produced negligible
luciferase activity (data not shown). Cells expressing the RlucN-
CheY3/CheZ-RlucC fusion pair grew poorly and were not
analyzed further. Thus, the CheY3-RlucN/CheZ-RlucC con-
struct, pYNZC, was used for all subsequent experiments. To
further maximize reporter activity, expression of fusion proteins
was induced with 0.2% arabinose, and the Rluc substrate that
yielded the highest luminescence (i.e., clz) was selected (Figure S1).
Notably, co-expression of CheY3-RlucN and CheZ-RlucC in
wild-type V. cholerae generated luciferase activity comparable to
that observed in the DcheY3cheZ mutant, demonstrating that the
endogenous CheY3 and CheZ proteins do not significantly inhibit
split Rluc complementation.
CheY3-CheZ Interaction is Markedly Reduced in
V. cholerae Chemotaxis Mutants
We hypothesized that pYNZC could be used to measure
changes in CheY3-CheZ interaction, and thus chemotactic
signaling, in V. cholerae mutants compromised for chemotaxis.
We introduced pYNZC into Dche2, a strain lacking all cluster II
chemotaxis genes (including cheY3 and cheZ), and Dche1che2che3,
which lacks all three chemotaxis clusters. Because cluster II genes
are required for chemotaxis under laboratory conditions [20,24],
both of these strains are non-chemotactic and were thus predicted
to have significantly fewer CheY3-CheZ interactions than wild-
type V. cholerae. As expected, the luciferase activities of both Dche2
and Dche1che2che3 were markedly lower than wild-type cells
(,70% reduction in luminescence intensity; Figure 3A). Immu-
noblotting confirmed that these differences were not due to
variable expression of the luciferase fragments from pYNZC in
these different genetic backgrounds (Figure 3B). Since Dche2 and
Dche1che2che3 exhibited approximately equal luminescence inten-
sities (Figure 3A), the additional chemotaxis signaling proteins
encoded by cluster II (e.g., cheA2, cheW1) are presumably the
primary mediators of CheY3-CheZ binding under these condi-
tions. However, a low level of split Rluc complementation was still
observed in these strains, raising the possibility that some
interactions between CheY3 and CheZ can occur despite the
absence of chemotaxis proteins that ostensibly regulate CheY3
phosphorylation (e.g., CheA2). Indeed, other factors, such as
CheY acetylation [28], have been shown to affect chemotactic
signaling in E. coli and may stimulate CheY3-CheZ binding in
V. cholerae independent of other chemotaxis machinery. Still, the
difference in reporter activity between wild-type and non-
Figure 2. Split Rluc complementation is dependent on fusing Rluc N- and C-terminal fragments to CheY3 and CheZ. Luminescence
generated by wild-type V. cholerae co-expressing CheY3-RlucN and CheZ-RlucC or unfused RlucN and RlucC. Data are reported as a percentage of the
highest initial signal intensity and represent the average of three technical replicates.
doi:10.1371/journal.pone.0043175.g002
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complementation as an indicator of chemotactic signaling in
different V. cholerae genetic backgrounds.
Nonspecific Inhibition of Rluc Precludes Analysis of
Dynamic CheY3-CheZ Interactions
ToassesstheutilityofsplitRluccomplementationformonitoring
changesinprotein-proteininteractionsinV.cholerae,weinvestigated
the effects of chemoeffector addition on pYNZC reporter activity.
Based on the BRET- and FRET-based assays for studying CheY-
CheZ interactions in E. coli [14,23], we expected the luciferase
activity generated by cells co-expressing CheY3-RlucN and CheZ-
RlucC to be proportional to chemotaxis pathway activity and to
reflectthereversibleassociationofCheY3andCheZproteins.Thus,
applying a chemoattractant to those cells should decrease CheY3
phosphorylation and the extent of CheY3-CheZ binding, resulting
in a rapid loss of luminescence. To test this, we treated wild-type V.
cholerae expressing these fusion proteins from pYNZC with several
well-characterized chemoattractants, including L-serine and D-
glucose[29].Thesemoleculesstimulatedarapid(withinoneminute)
and significant decreasein cellular luminescencerelative to awater-
only control (Figure 4A). Maximal effects were observed following
addition of these factors at 1 mM; however, addition of known
attractants at much lower concentrations (,1 mM) also reduced
luminescence (data not shown). Thus, chemoattractant addition
appeared to reduce the interaction between CheY3 (presumably as
CheY3-P) and CheZ as expected, suggesting that split Rluc
complementation was indeed reversible.
Though initially promising, several aspects of the CheY3-CheZ
response to chemoattractant addition were inconsistent with
published reports of bacterial chemotactic signaling and prompted
us to question the significance of these data. First, not all
chemoeffectors had the anticipated effect on split Rluc comple-
mentation. For example, L-arginine, a strong V. cholerae chemoat-
tractant [29,30], did not decrease luciferase activity (Figure 4A).
Furthermore, some common bacterial repellents, such as nickel
chloride, cobalt chloride, and butyric acid [31,32], which were
expected to stimulate CheY3 phosphorylation, enhance binding to
CheZ, and thus increase split Rluc complementation, instead
elicited an ‘‘attractant-like’’ response (e.g., Figure 4A, nickel
chloride). Finally, the signal recovery typically observed shortly
after attractant addition in BRET- and FRET-based assays
[14,23], which reflects MCP adaptation to local chemical
gradients, was notably absent from our split Rluc data. In light
of these issues, we began to suspect that our Rluc PCA was not
accurately reporting changes in CheY3-CheZ interactions in
response to chemotactic stimuli.
To explore the possibility that certain chemoeffectors might
nonspecifically inhibit Rluc activity, generating a false ‘‘attractant-
like’’ response, we monitored the effect of chemoeffector treatment
upon cells expressing the full-length enzyme. Remarkably, we
observed a decrease in luminescence that mirrored nearly exactly
the response of cells co-expressing CheY3-RlucN and CheZ-
RlucC (compare Figure 4A and Figure 4B), thereby confirming
our suspicion that nonspecific inhibition of Rluc was compromis-
ing the significance of the split Rluc data. Notably, we observed a
similar inhibition profile in E. coli expressing the full-length
Figure 3. Rluc PCA detects reduced CheY3-CheZ interaction in V. cholerae chemotaxis mutants. (A) Luminescence generated by wild-type
( ),Dche2 ( ), and Dche1che2che3 ( ) V. cholerae co-expressing CheY3-RlucN and CheZ-RlucC. Data from three biological replicates were
normalized by optical density, averaged, and reported as a percentage of the highest initial signal intensity. (B) Western blot analysis of CheY3-RlucN/
CheZ-RlucC expression in samples from (A). Only the CheZ-RlucC fusion protein was detected by the monoclonal anti-Rluc antibody.
doi:10.1371/journal.pone.0043175.g003
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in other bacteria. Furthermore, nonspecific inhibition of Rluc
activity was observed regardless of the order of reagent addition.
For example, pretreatment of cells expressing CheY3-RlucN/
CheZ-RlucC or the full-length enzyme with L-serine followed
immediately by clz addition and measurement of Rluc activity
decreased luminescence intensity by at least 65% relative to cells
pretreated with water or L-arginine. Thus, we were unable to
validate the reversibility of CheY3-CheZ-mediated split Rluc
complementation, precluding its utility as a tool for evaluating
dynamic chemotactic responses.
Discussion
We sought to develop a new method for quantitatively probing
real-time protein-protein interactions in live bacteria using split
luciferase complementation, a technique that has been widely
applied to study protein-protein interactions in mammalian cells
[3]. As proof of concept, we chose to develop an Rluc-based PCA
for V. cholerae chemotaxis by fusing two inactive Rluc fragments to
the chemotaxis response regulator CheY3 and its cognate
phosphatase CheZ. In E. coli, BRET and FRET have been used
to study the transient, phosphorylation-dependent interaction of
CheY and CheZ proteins, which is directly proportional to
chemotaxis pathway activity [14,23]. We hypothesized that split
Rluc complementation could provide an alternative means of
studying these interactions in V. cholerae, establishing a rapid,
highly tractable, microplate-based assay for bacterial chemotaxis
with the potential for high-throughput applications.
Consistent with a previous study that used Gaussia princeps
luciferase complementation to detect assembly of a stable protein
complex in Salmonella [13], we found that fusion of Rluc fragments
to known chemotaxis interaction partners enabled reconstitution
Figure 4. Apparent chemoattractant response of Rluc PCA reflects nonspecific inhibition of full-length Rluc. Luminescence generated
by wild-type V. cholerae co-expressing CheY3-RlucN and CheZ-RlucC from pYNZC (A) or unfused, full-length Rluc from pRluc (B) was measured before
and after treatment with 1 mM D-glucose, L-alanine, or nickel chloride (top panel) and 1 mM L-serine, D-mannose, or L-arginine (bottom panel) or an
equal volume of water. Luminescence generated by wild-type E. coli expressing full-length Rluc from pRluc was measured before and after treatment
with L-serine, L-arginine, or water (C). Reagent addition is denoted by an arrow. Data are reported as a percentage of the highest initial signal
intensity and represent the average of three technical replicates.
doi:10.1371/journal.pone.0043175.g004
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we discovered that the CheY3-CheZ-dependent signal was
reduced in chemotaxis-deficient V. cholerae strains, suggesting that
this system serves as a reporter of basal chemotactic signaling
(Figure 3). However, our attempts to measure changes in
chemotactic signaling in response to the addition of known
chemoattractants, which should decrease CheY3-CheZ interac-
tions, and hence, the associated split Rluc signal, were compro-
mised by the unexpectedly broad small molecule inhibition profile
of the full-length Rluc enzyme (Figure 4). These findings
demonstrate the need for great caution in interpreting chemical
effects on dynamic protein-protein interactions using split Rluc
complementation.
Importantly, we performed our assays under conditions that
yield a relatively stable split Rluc signal in order to more easily
compare enzyme activity before and after chemoeffector addition.
We determined that pre-incubation of cells with clz for 30 minutes
prior to measuring luminescence was typically sufficient to achieve
a stable signal (e.g., Figure 2 and Figure 3A), though a gradual
decrease in Rluc activity was sometimes still observed despite this
incubation period (e.g., Figure 4A). In mammalian cell-based Rluc
PCAs, bioluminescence is typically measured immediately follow-
ing clz addition because maximal luminescence occurs after an
initial burst in Rluc activity (typically within the first minute of clz
addition) [10,11]. Though we obtained similar results using this
approach (i.e., pretreatment of cells with L-serine followed by clz
addition significantly decreased luminescence intensity relative to
cells pretreated with water or L-arginine), we found that pre-
incubation of the cells with clz facilitated more quantitative
comparisons between different chemoeffectors. However, nonspe-
cific inhibition of full-length Rluc was evident regardless of the
order of reagent addition.
Chemical inhibition of luciferases, which has been previously
documented, can complicate their use as both transcriptional and
biochemical reporters [33–36]. Even so, we were greatly surprised
by the breadth of the inhibition we observed, as the majority of the
compounds we tested appeared to reduce Rluc activity. Notably,
these inhibitory compounds (i.e., L-serine, L-alanine, D-glucose,
D-mannose, and nickel chloride) are quite structurally dissimilar
from clz, the Rluc substrate, suggesting that their inhibitory effects
most likely result from some nonspecific mode of inhibition, rather
than from direct competition with clz for access to the enzyme’s
active site. For example, it is possible these molecules compromise
protein fold, photonic processes, or form inhibitory aggregates that
decrease the luminescent signal [33].
We considered the possibility that low concentrations of these
molecules might not inhibit full-length Rluc, but still be potent
enough to affect chemotactic signaling and elicit a meaningful
response from the Rluc PCA. However, chemoeffector concen-
trations at the detection limit of the assay (,1 mM) resulted in
significant Rluc inhibition (data not shown), rendering the system
untenable. Furthermore, the lack of a response to L-arginine
(Figure 4A), a strong V. cholerae chemoattractant that should in
principle decrease CheY3-RlucN/CheZ-RlucC interactions and
the corresponding luminescent signal, suggests that the binding of
these two fusion proteins may be irreversible. While this possibility
is unexpected, there may be factors specific to this application (e.g.,
altered folding kinetics of Rluc fragments in bacteria, unforeseen
effects of Rluc fusions on CheY3-CheZ phosphotransfer) that
compromise the previously demonstrated reversibility of split
luciferase complementation observed in eukaryotes.
Split luciferase is a powerful tool for measuring protein-protein
interactions in live cells. However, our observations demonstrate
an essential control for these studies: when investigating the effects
of small molecules on dynamic protein-protein interactions, cells
expressing the full-length luciferase must also be tested to ensure
that compounds of interest truly inhibit protein interactions and
not the activity of the reconstituted luciferase. A review of the split
luciferase literature revealed that this control is seldom performed.
Thus, we urge caution when applying this system to identify small
molecule effectors of dynamic protein-protein interactions.
Supporting Information
Figure S1 Split Rluc signal is influenced by inducer
concentration and Rluc substrate. Luminescence generated
by wild-type V. cholerae co-expressing CheY3-RlucN and CheZ-
RlucC following induction with either 0.01% ( ) or 0.2% ( )L -
arabinose and treatment with native coelenterazine (clz) (A), or
induction with 0.2% L-arabinose and treatment with either clz ( )
or benzyl-coelenterazine (clz-h, )( B). Data are reported as a
percentage of the highest initial signal intensity and represent the
average of three technical replicates.
(TIF)
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